Patents
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
02/1998
02/11/1998EP0822984A1 Human tumor necrosis factor receptors
02/11/1998EP0822977A1 Modified cells and methods for inhibiting xenograft rejection
02/11/1998EP0822942A1 Modified anti-icam-1 antibodies and their use in the treatment of inflammation
02/11/1998EP0822941A1 Monoclonal antibodies against hiv-1 and vaccines made thereof
02/11/1998EP0822939A1 Cyclic pentapeptide lh-rh receptor antagonists
02/11/1998EP0822934A1 Antithrombotic amidinotetrahydropyridylalanine derivatives
02/11/1998EP0822834A1 Recombinant (beta)-cell and uses thereof
02/11/1998EP0822832A1 Cd45rb binding compounds for the prevention of transplant rejection
02/11/1998EP0822830A1 Human antibodies derived from immunized xenomice
02/11/1998EP0822829A1 Use of glial neurotrophic factor (gdnf) for treatment of hearing disorders
02/11/1998EP0822828A1 Isolated 55 to 75 kda protein which binds to prion protein
02/11/1998EP0822827A1 Antagonists of lhrh
02/11/1998EP0822826A1 Nitrosylated neuropeptides
02/11/1998EP0730740B1 Kinase receptor activation assay
02/11/1998EP0714407B1 Composition and methods using nitroxides to avoid oxygen toxicity
02/11/1998EP0624164B1 Peptides with organo-protective activity, process for their preparation and their use in the therapy
02/11/1998EP0500734B1 Protein complexes having factor viii:c activity and production thereof
02/11/1998CN1173206A Antitumor and anticholesterol preparations containing a lipoteichoic acid from steptococcus
02/11/1998CN1173204A Immunogens for stimulating mucosal immunity
02/11/1998CN1173203A Purified papillomavirus proteins
02/11/1998CN1173184A Identitication, purification and uses of leczymes and carbohydrate ligands
02/11/1998CN1173183A Conjugates of BDNF and NT-3 with a water-soluble polymer
02/11/1998CN1173174A Substituted oxazolidine calpain and/or cathepsin B inhibitors
02/11/1998CN1173170A Matrix metalloprotease inhibitors
02/11/1998CN1173141A Centrifuge with annular fiter
02/11/1998CN1173140A Method and device for separating hemaleucin fibrin from blood blasma
02/11/1998CN1173136A Method for stimulating erythropoiesis using hematopoietic proteins
02/11/1998CN1172811A Insulin derivatives with increased zinc binding
02/11/1998CN1172591A Dietetic foods and pharmaceutical preparations inhibiting blood coagulation
02/11/1998CN1037350C Method for preparing polypeptide derivative
02/10/1998US5717092 Compounds with improved multi-drug resistance activity
02/10/1998US5717074 Macrophage-derived inflammatory mediator (MIP-2)
02/10/1998US5717073 Anti-gp130 monoclonal antibodies
02/10/1998US5717072 For suppressing immune or inflammatory response in mammals
02/10/1998US5717071 Culture product bactericide specific binding to lipopolysaccharide of outer membrane for treating bacterial infection
02/10/1998US5717070 Culture product
02/10/1998US5717069 Insecticide
02/10/1998US5717067 Purified polypeptide
02/10/1998US5717064 Enhanced resistance to proteolytic digestion
02/10/1998US5717063 Veterinary medicine; nematodes
02/10/1998US5717062 Cyclic analogs of PTH and PTHrP
02/10/1998US5717061 Synthetic antimicobial peptides
02/10/1998US5717058 Viricides, treatment of genetic disorders
02/10/1998US5716981 A stent coated with paclitaxel, a taxan derivative and a polymeric carrier; medical equipment for deblocking
02/10/1998US5716980 Alcohol or aldehyde derivatives and their use
02/10/1998US5716962 Treating hyperglycemia and hyperinsulinemia
02/10/1998US5716957 Administering a hypoglycemic agent or dopaminergic agent once a day and within two hours after waking in morning
02/10/1998US5716937 Method for treating cardiac malfunction
02/10/1998US5716936 Pyrrolidine derivatives for the treatment of cholecystokinine and gastrine-related disorders
02/10/1998US5716935 Applying polypeptide in carrier to wound to accelerate healing
02/10/1998US5716934 Eck receptor ligands
02/10/1998US5716933 Adjustment the prolactin and glucoccorticosteroid ratio in blood
02/10/1998US5716932 Process for the long term reduction of body fat stores, insulin resistance, and hyperinsulinemia in vertebrates
02/10/1998US5716931 Administering lantibiotic by aerosol
02/10/1998US5716930 Polypeptide from genetically engineered cells
02/10/1998US5716929 Inhibitors of interleukin-1β converting enzyme
02/10/1998US5716928 Use of essential oils to increase bioavailability of oral pharmaceutical compounds
02/10/1998US5716927 Insulin analogs having a modified B-chain
02/10/1998US5716846 Method for inhibiting cellular proliferation using antisense oligonucleotides to interleukin-6 receptor mRNA
02/10/1998US5716838 Culture of microorganisms such as rhizobium, arthrobacter
02/10/1998US5716832 Growing packaging cells having viral protein-coding sequences which produce target cell-specific retroviruses; gene therapy, antitumor agents
02/10/1998US5716827 Capable of regeneration
02/10/1998US5716826 Recombinant retroviruses
02/10/1998US5716823 Human respiratory virus preparahons and processess
02/10/1998US5716817 Dna molecule containing intron sequence; bile salt stimulated lipase or carboxy ester lipase
02/10/1998US5716813 DNA encoding enzyme, recombinant DNA and enzyme, transformant, and their preparations and uses
02/10/1998US5716810 Nucleic acid encoding the mature βB chain of inhibin and method for synthesizing polypeptides using such nucleic acid
02/10/1998US5716806 Genetic engineering; medical diagnosis
02/10/1998US5716805 Methods of preparing soluble, oligomeric proteins
02/10/1998US5716804 Mammalian interleukin-10 (IL-10) super-activating receptors; and variants
02/10/1998US5716789 Incubating cells; measuring activation
02/10/1998US5716787 Immunological detection method for organ transplant rejection
02/10/1998US5716782 Nucleic acid encoding a signal mediator protein that induces cellular morphological alterations
02/10/1998US5716648 Compositions for use in the regulation of subnormal pH values in the intestinal tract and for treatment of bowel diseases
02/10/1998US5716645 Pooled plasma-derived fibrinogen cryoprecipitate free of antifibrinolytic agents, nonhuman proteins and viruses; hemostatic agents, tensile strength
02/10/1998US5716644 Lyophilized solution containing erythropoietin, ammonium sulfate, ph 5-7 buffer
02/10/1998US5716640 Water in oil emulsion
02/10/1998US5716623 Isolated Herpesvirus saimiri proteins that bind MHC Class II molecules
02/10/1998US5716622 Functionally active regions of signal transducer and activators of transcription
02/10/1998US5716619 Treatment of type 2 diabetes mellitus
02/10/1998US5716617 Concurrent purification of mixture
02/10/1998US5716616 Sampling bone marrow; adminstering by intravenous infusion
02/10/1998US5716613 Genetic engineering
02/10/1998US5716612 Desensitizing the cancer cell drug resistance
02/10/1998US5716596 Radioactively labeled somatostatin-derived peptides for imaging and therapeutic uses
02/10/1998US5716595 Intraperative, intravascular and endoscopic tumor and lesion detection and therapy with monovalent antibody fragments
02/10/1998US5715835 Methods for treating and reducing the potential for cardiovascular disease using methioninase compositions
02/10/1998CA2053258C Use of non-absorbable synthetic sulfated polysaccharides to decrease cholesterol absorption
02/05/1998WO1998004913A1 Molecular model for vla-4 inhibitors
02/05/1998WO1998004727A1 Recombinant pox virus for immunization against tumor-associated antigens
02/05/1998WO1998004719A1 A biovector
02/05/1998WO1998004718A1 Fusion polypeptides comprising an ige-binding domain and a hsa component, and their diagnostic and therapeutic uses
02/05/1998WO1998004717A2 Double-stranded rna dependent protein kinase derived peptides to promote proliferation of cells and tissues in a controlled manner
02/05/1998WO1998004714A1 A NOVEL HUMAN mRNA EDITING ENZYME
02/05/1998WO1998004712A2 Substrate trapping protein tyrosine phosphatases
02/05/1998WO1998004709A2 Herpes simplex virus icp4 is an inhibitor of apoptosis
02/05/1998WO1998004708A1 Anti-herpesviral agents and assays therefor
02/05/1998WO1998004707A1 Anti-herpesviral agent
02/05/1998WO1998004705A1 Pharmaceutical composition for treating papillomavirus tumours and infection
02/05/1998WO1998004702A2 Proteins, in particular membrane proteins, of helicobacter pylori, their preparation and use